Somatostatin-Derived Amyloidosis: A Novel Type of Amyloidosis Associated with Well-Differentiated Neuroendocrine Tumors

被引：0
|
作者：
Said, Samar [1 ]
VanTreeck, Benjamin [1 ]
Dasari, Surendra [1 ]
Kurtin, Paul [1 ]
Theis, Jason [1 ]
Nasr, Samih [1 ]
Zhang, Lizhi [1 ]
Yasir, Saba [1 ]
Graham, Rondell [1 ]
McPhail, Ellen [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
来源：
MODERN PATHOLOGY | 2021年 / 34卷 / SUPPL 2期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
883
引用
收藏
页码：1055 / 1056
页数：2
相关论文
共 50 条
  • [41] Clinicopathological characteristics and prognosis of rectal well-differentiated neuroendocrine tumors
    Shunsuke Tsukamoto
    Shin Fujita
    Tomohiro Yamaguchi
    Seiichiro Yamamoto
    Takayuki Akasu
    Yoshihiro Moriya
    Hirokazu Taniguchi
    Tadakazu Shimoda
    International Journal of Colorectal Disease, 2008, 23 : 1109 - 1113
  • [42] Treatment of advanced disease in patients with well-differentiated neuroendocrine tumors
    Reidy, Diane L.
    Tang, Laura H.
    Saltz, Leonard B.
    NATURE CLINICAL PRACTICE ONCOLOGY, 2009, 6 (03): : 143 - 152
  • [43] Well-differentiated pancreatic neuroendocrine tumors: from genetics to therapy
    Roeland F. de Wilde
    Barish H. Edil
    Ralph H. Hruban
    Anirban Maitra
    Nature Reviews Gastroenterology & Hepatology, 2012, 9 : 199 - 208
  • [44] Clinical and Pathological Behavior of Well-Differentiated Pancreatic Neuroendocrine Tumors
    Perez-Casanova, Luis
    Serrano, Teresa
    Navas, Carlos
    Salazar, Ramon
    Villabona, Carlos
    Valls, Carles
    Fabregat, Juan
    Condom, Enric
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2014, 142
  • [45] Molecular profiling of well-differentiated neuroendocrine tumors: Role of ctDNA
    Lamarca, A.
    Frizziero, M.
    Barriuso, J.
    Kapacee, Z. A.
    Mansoor, W.
    McNamara, M.
    Hubner, R.
    Valle, J.
    JOURNAL OF NEUROENDOCRINOLOGY, 2021, 33 : 30 - 30
  • [46] Somatostatin receptor scintigraphy and chromogranin A assay in staging and follow-up of patients with well-differentiated neuroendocrine tumors
    Stokkel, Marcel P. M.
    Rietbergen, Daphne D.
    Korse, Catharina M.
    Taal, Babs G.
    NUCLEAR MEDICINE COMMUNICATIONS, 2011, 32 (08) : 731 - 737
  • [47] Nonconventional Doses of Somatostatin Analogs in Patients With Progressing Well-Differentiated Neuroendocrine Tumor
    Lamberti, Giuseppe
    Faggiano, Antongiulio
    Brighi, Nicole
    Tafuto, Salvatore
    Ibrahim, Toni
    Brizzi, Maria Pia
    Pusceddu, Sara
    Albertelli, Manuela
    Massironi, Sara
    Panzuto, Francesco
    Badalamenti, Giuseppe
    Riccardi, Ferdinando
    Butturini, Giovanni
    Gelsomino, Fabio
    De Divitiis, Chiara
    Modica, Roberta
    Bongiovanni, Alberto
    La Salvia, Anna
    Torchio, Martina
    Colao, Annamaria
    Ferone, Diego
    Campana, Davide
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 105 (01): : 194 - 200
  • [48] Characterization of a novel entity of high-grade well-differentiated colorectal neuroendocrine tumors.
    Punekar, Salman Rafi
    Masri-Lavine, Lena
    Hajdu, Cristina
    Newman, Elliot
    Becker, Daniel Jacob
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [49] Novel fluoropyrimidine-based chemotherapy for advanced well-differentiated neuroendocrine tumors: a clinical update
    Zhang, Heling
    Shen, Guoshuang
    Zhang, Shuisheng
    Du, Feng
    Cao, Yang
    Jiang, Jun
    Zheng, Fangchao
    Ma, Xinfu
    Wang, Ziyi
    Ren, Dengfen
    Ahmad, Raees
    Zhao, Fuxin
    Zhao, Jiuda
    EXPERT OPINION ON PHARMACOTHERAPY, 2018, 19 (08) : 795 - 807
  • [50] Treatment Outcomes of Well-Differentiated High-Grade Neuroendocrine Tumors
    Liu, Alex J.
    Ueberroth, Benjamin E.
    McGarrah, Patrick W.
    Buckner Petty, Skye A.
    Kendi, Ayse Tuba
    Starr, Jason
    Hobday, Timothy J.
    Halfdanarson, Thorvardur R.
    Sonbol, Mohamad Bassam
    ONCOLOGIST, 2021, 26 (05): : 383 - 388
12345